COVID-19 linked to rise in anti-MDA5 autoimmunity | Nature Reviews Rheumatology Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …

Introduction The SARS-CoV-2 infection has been advocated as an environmental trigger for
autoimmune diseases, and a paradigmatic example comes from similarities between COVID …

Introduction: Anti-Melanoma Differentiation-Associated Gene 5 (MDA-5) myositis is a rare
subset of dermatomyositis known for its association with rapidly progressive interstitial lung …

Respiratory complaints and nonspecific systemic symptoms combined with bilateral ground
glass opacities on chest imaging constitute the clinical and radiological picture of both …

Discussion: Anti-MDA5 antibody positivity has been implicated in rapidly progressive ILD
often refractory to conventional treatments like steroids. While this patient's pathology …

The direct causes of dermatomyositis, a common autoimmune disease, have not yet been
accurately identified, but several studies have linked this condition to various patient …

Coronavirus disease 2019 (COVID-19) is a newly recognized systemic condition due to the
SARS-CoV-2 infection. As rheumatologists, we often found analogies between vascular …

Background Autoimmune disease following COVID-19 has been studied intensely since the
beginning of the pandemic. Growing evidence indicates that SARS-CoV-2 infection, by …

Background: Anti-MDA5 (Melanoma differentiation-associated protein-5) positive
dermatomyositis (MDA5+-DM) is characterised by rapidly progressive interstitial lung …

Summary Background Anti-MDA5 (Melanoma differentiation-associated protein-5) positive
dermatomyositis (MDA5+-DM) is characterised by rapidly progressive interstitial lung …